“…It is accepted that, when NPs enter (patho)physiological environments, proteins and other biomolecules bind to the nanomaterial surface, leading to the rapid formation of a biomolecule corona. The corona may be critically codefining the biological, medical, biotechnological, and pathophysiological identity of NPs, although the mechanistic details have not been resolved in detail. − As the impact of the corona can still not be predicted reliably, the design of NPs with low biomolecule adsorption properties is desirable and can be achieved by several chemical functionalization strategies. , Here, the use of polypept(o)ide-based formulations promise good colloidal stability, biocompatibility (low immunogenicity, low toxicity, prolonged in vivo circulation, no complement activation, no plasma protein aggregation), and low corona formation properties. Polypept(o)ides are hybrid copolymers combining polypeptides with the polypeptoid polysarcosine (pSar, poly( N -methyl glycine)), which is biologically well-tolerated. , pSar is considered a promising alternative to poly(ethylene glycol), showing advantages of reduced proinflammatory cytokine secretion, reduced complement activation, and evasion of the accelerated blood clearance (ABC) phenomenon. − …”